Doris Taylor

As a pioneer in cardiovascular regenerative medicine from bench to bedside, Dr. Taylor is credited with a number of important scientific breakthroughs related to cell and gene therapy, stem cell biology, and tissue engineering. Her work has been published in Nature Medicine, Circulation Research, The Journal of Molecular Biology, The Journal of Biochemistry, Journal of the American College of Cardiology (JACC), Journal of the American Medical Association (JAMA), and other top-tier scientific journals. She holds a number of invention disclosures, patent applications and patents and is the founder of multiple companies dedicated to cardiovascular repair technologies. She is a member of the Society for Women's Health Research (SWHR) Cardiovascular Working Group and the Organization for the Study of Sex Differences (OSSD). Other professional affiliations include the American Association for the Advancement of Science (AAAS), the American Heart Association (AHA), and the Federation of American Societies for Experimental Biology (FASEB), among others. She recently served on the Executive Committee for the Alliance for Regenerative Medicine (ARM).

Dr. Taylor holds many honors including appointments as a Fellow for the American Heart Association (AHA), the American College of Cardiology and the European Society of Cardiology among other organizations. She has held faculty and or leadership appointments at Duke University Medical Center, University of Minnesota Medical School, Texas Heart Institute, Texas A&M University, and Rice University, as well as an honorary medical professorship in Krasnodar Russia.